4/18/2011

Synta Pharmaceuticals pulled in $35 million in a stock placement to support its research and development efforts, manufacturing operations and other corporate functions. The biopharmaceutical firm also secured a $2 million loan that it will use to buy laboratory tools to test drug candidates for cancer and chronic inflammatory conditions.

Related Summaries